BioSmart Research
BioSmart Research: nutraceutical CBD isolates for professional distribution
Overview
Raised: $53,400
Rolling Commitments ($USD)
12/30/2021
$332
25
2019
Healthcare & Pharmaceuticals
Biotech
B2B/B2C
Low
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$52,952 |
$1,873,578 |
COGS |
$0 |
$1,497,859 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-149,247 |
$74,730 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$49,777 |
$68,970 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$2,627,387 |
$2,472,260 |
Short-Term Debt |
$113,067 |
$2,314 |
Long-Term Debt |
$127,210 |
$112,577 |
Total Liabilities |
$240,277 |
$114,891 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual